General Information of Drug Off-Target (DOT) (ID: OTR473H8)

DOT Name Actin filament-associated protein 1 (AFAP1)
Synonyms 110 kDa actin filament-associated protein; AFAP-110
Gene Name AFAP1
Related Disease
Attenuated familial adenomatous polyposis ( )
Benign prostatic hyperplasia ( )
Breast cancer ( )
Breast carcinoma ( )
Breast neoplasm ( )
Carcinoma ( )
Cervical cancer ( )
Cervical carcinoma ( )
Cholangiocarcinoma ( )
Congenital contractural arachnodactyly ( )
Endometriosis ( )
Esophageal adenocarcinoma ( )
Esophageal cancer ( )
Familial adenomatous polyposis ( )
Gastric cancer ( )
Lung cancer ( )
Lung carcinoma ( )
Nasopharyngeal carcinoma ( )
Neoplasm ( )
Non-small-cell lung cancer ( )
Open-angle glaucoma ( )
Polyp ( )
Prostate cancer ( )
Prostate carcinoma ( )
Stomach cancer ( )
Glaucoma/ocular hypertension ( )
Advanced cancer ( )
Colorectal adenoma ( )
Colorectal carcinoma ( )
Familial adenomatous polyposis 2 ( )
OPTN-related open angle glaucoma ( )
Pancreatic cancer ( )
Polyposis ( )
UniProt ID
AFAP1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00169
Sequence
MEELIVELRLFLELLDHEYLTSTVREKKAVITNILLRIQSSKGFDVKDHAQKQETANSLP
APPQMPLPEIPQPWLPPDSGPPPLPTSSLPEGYYEEAVPLSPGKAPEYITSNYDSDAMSS
SYESYDEEEEDGKGKKTRHQWPSEEASMDLVKDAKICAFLLRKKRFGQWTKLLCVIKDTK
LLCYKSSKDQQPQMELPLQGCNITYIPKDSKKKKHELKITQQGTDPLVLAVQSKEQAEQW
LKVIKEAYSGCSGPVDSECPPPPSSPVHKAELEKKLSSERPSSDGEGVVENGITTCNGKE
QVKRKKSSKSEAKGTVSKVTGKKITKIISLGKKKPSTDEQTSSAEEDVPTCGYLNVLSNS
RWRERWCRVKDNKLIFHKDRTDLKTHIVSIPLRGCEVIPGLDSKHPLTFRLLRNGQEVAV
LEASSSEDMGRWIGILLAETGSSTDPEALHYDYIDVEMSASVIQTAKQTFCFMNRRVISA
NPYLGGTSNGYAHPSGTALHYDDVPCINGSLKGKKPPVASNGVTGKGKTLSSQPKKADPA
AVVKRTGSNAAQYKYGKNRVEADAKRLQTKEEELLKRKEALRNRLAQLRKERKDLRAAIE
VNAGRKPQAILEEKLKQLEEECRQKEAERVSLELELTEVKESLKKALAGGVTLGLAIEPK
SGTSSPQSPVFRHRTLENSPISSCDTSDTEGPVPVNSAAVLKKSQAAPGSSPCRGHVLRK
AKEWELKNGT
Function
Can cross-link actin filaments into both network and bundle structures. May modulate changes in actin filament integrity and induce lamellipodia formation. May function as an adapter molecule that links other proteins, such as SRC and PKC to the actin cytoskeleton. Seems to play a role in the development and progression of prostate adenocarcinoma by regulating cell-matrix adhesions and migration in the cancer cells.
Tissue Specificity
Low expression in normal breast epithelial cell line MCF-10A and in tumorigenic breast cancer cell lines MCF-7, T-47D and ZR-75-1. Highly expressed in the invasive breast cancer cell lines MDA-MB-231 and MDA-MB-435. Overexpressed in prostate carcinoma.

Molecular Interaction Atlas (MIA) of This DOT

33 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Attenuated familial adenomatous polyposis DISGMTLG Definitive Genetic Variation [1]
Benign prostatic hyperplasia DISI3CW2 Strong Altered Expression [2]
Breast cancer DIS7DPX1 Strong Biomarker [3]
Breast carcinoma DIS2UE88 Strong Biomarker [3]
Breast neoplasm DISNGJLM Strong Biomarker [4]
Carcinoma DISH9F1N Strong Altered Expression [2]
Cervical cancer DISFSHPF Strong Biomarker [5]
Cervical carcinoma DIST4S00 Strong Biomarker [5]
Cholangiocarcinoma DIS71F6X Strong Biomarker [6]
Congenital contractural arachnodactyly DISOM1K7 Strong Biomarker [6]
Endometriosis DISX1AG8 Strong Biomarker [7]
Esophageal adenocarcinoma DISODWFP Strong Altered Expression [8]
Esophageal cancer DISGB2VN Strong Altered Expression [9]
Familial adenomatous polyposis DISW53RE Strong Biomarker [10]
Gastric cancer DISXGOUK Strong Altered Expression [11]
Lung cancer DISCM4YA Strong Altered Expression [12]
Lung carcinoma DISTR26C Strong Altered Expression [12]
Nasopharyngeal carcinoma DISAOTQ0 Strong Biomarker [13]
Neoplasm DISZKGEW Strong Altered Expression [12]
Non-small-cell lung cancer DIS5Y6R9 Strong Biomarker [14]
Open-angle glaucoma DISSZEE8 Strong Genetic Variation [15]
Polyp DISRSLYF Strong Biomarker [10]
Prostate cancer DISF190Y Strong Altered Expression [2]
Prostate carcinoma DISMJPLE Strong Altered Expression [2]
Stomach cancer DISKIJSX Strong Altered Expression [11]
Glaucoma/ocular hypertension DISLBXBY moderate Genetic Variation [16]
Advanced cancer DISAT1Z9 Limited Biomarker [17]
Colorectal adenoma DISTSVHM Limited Genetic Variation [18]
Colorectal carcinoma DIS5PYL0 Limited Biomarker [19]
Familial adenomatous polyposis 2 DIS62W3Y Limited Biomarker [10]
OPTN-related open angle glaucoma DISDR98A Limited Genetic Variation [20]
Pancreatic cancer DISJC981 Limited Biomarker [21]
Polyposis DISZSPOK Limited Genetic Variation [18]
------------------------------------------------------------------------------------
⏷ Show the Full List of 33 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
9 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Actin filament-associated protein 1 (AFAP1). [22]
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of Actin filament-associated protein 1 (AFAP1). [23]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Actin filament-associated protein 1 (AFAP1). [24]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Actin filament-associated protein 1 (AFAP1). [25]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Actin filament-associated protein 1 (AFAP1). [26]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide increases the expression of Actin filament-associated protein 1 (AFAP1). [29]
Folic acid DMEMBJC Approved Folic acid affects the expression of Actin filament-associated protein 1 (AFAP1). [30]
Hydroquinone DM6AVR4 Approved Hydroquinone decreases the expression of Actin filament-associated protein 1 (AFAP1). [31]
Trichostatin A DM9C8NX Investigative Trichostatin A increases the expression of Actin filament-associated protein 1 (AFAP1). [33]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Drug(s)
4 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of Actin filament-associated protein 1 (AFAP1). [27]
Quercetin DM3NC4M Approved Quercetin increases the phosphorylation of Actin filament-associated protein 1 (AFAP1). [28]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Actin filament-associated protein 1 (AFAP1). [32]
Coumarin DM0N8ZM Investigative Coumarin affects the phosphorylation of Actin filament-associated protein 1 (AFAP1). [28]
------------------------------------------------------------------------------------

References

1 Mitochondrial variants in MT-CO2 and D-loop instability are involved in MUTYH-associated polyposis.J Mol Med (Berl). 2015 Nov;93(11):1271-81. doi: 10.1007/s00109-015-1312-0. Epub 2015 Jul 3.
2 AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts.J Clin Invest. 2007 Oct;117(10):2962-73. doi: 10.1172/JCI30710.
3 Expression analysis of AFAP1-AS1 and AFAP1 in breast cancer.Cancer Biomark. 2018;22(1):49-54. doi: 10.3233/CBM-170831.
4 AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells.J Cell Physiol. 2007 Dec;213(3):740-9. doi: 10.1002/jcp.21143.
5 Upregulation and hypomethylation of lncRNA AFAP1AS1 predicts a poor prognosis and promotes the migration and invasion of cervical cancer.Oncol Rep. 2019 Apr;41(4):2431-2439. doi: 10.3892/or.2019.7027. Epub 2019 Feb 21.
6 LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells.Oncotarget. 2017 Apr 6;8(35):58394-58404. doi: 10.18632/oncotarget.16880. eCollection 2017 Aug 29.
7 Long non-coding RNA AFAP1-AS1 promoting epithelial-mesenchymal transition of endometriosis is correlated with transcription factor ZEB1.Am J Reprod Immunol. 2019 Jan;81(1):e13074. doi: 10.1111/aji.13074. Epub 2018 Dec 19.
8 Long noncoding RNA actin filament-associated protein 1 antisense RNA 1 promotes malignant phenotype through binding with lysine-specific demethylase 1 and repressing HMG box-containing protein 1 in non-small-cell lung cancer.Cancer Sci. 2019 Jul;110(7):2211-2225. doi: 10.1111/cas.14039. Epub 2019 May 29.
9 AFAP1-AS1: A novel oncogenic long non-coding RNA in human cancers.Cell Prolif. 2018 Feb;51(1):e12397. doi: 10.1111/cpr.12397. Epub 2017 Oct 22.
10 Colorectal Adenomatous Polyposis: Heterogeneity of Susceptibility Gene Mutations and Phenotypes in a Cohort of Italian Patients.Genet Test Mol Biomarkers. 2016 Dec;20(12):777-785. doi: 10.1089/gtmb.2016.0198. Epub 2016 Oct 5.
11 Circulatinglong non-coding RNA FEZF1-AS1 and AFAP1-AS1 serve as potential diagnostic biomarkers for gastric cancer.Pathol Res Pract. 2020 Jan;216(1):152757. doi: 10.1016/j.prp.2019.152757. Epub 2019 Nov 22.
12 Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma.Oncol Res. 2019 Jun 21;27(6):653-661. doi: 10.3727/096504018X15420748671075. Epub 2019 Mar 4.
13 Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway.J Exp Clin Cancer Res. 2018 Oct 16;37(1):253. doi: 10.1186/s13046-018-0918-9.
14 LncRNA AFAP1-AS1 Supresses miR-139-5p and Promotes Cell Proliferation and Chemotherapy Resistance of Non-small Cell Lung Cancer by Competitively Upregulating RRM2.Front Oncol. 2019 Oct 22;9:1103. doi: 10.3389/fonc.2019.01103. eCollection 2019.
15 A multiethnic genome-wide association study of primary open-angle glaucoma identifies novel risk loci.Nat Commun. 2018 Jun 11;9(1):2278. doi: 10.1038/s41467-018-04555-4.
16 Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies.Nat Genet. 2018 Sep;50(9):1335-1341. doi: 10.1038/s41588-018-0184-y. Epub 2018 Aug 13.
17 Overexpression of lncRNA AFAP1-AS1 promotes cell proliferation and invasion in gastric cancer.Oncol Lett. 2019 Sep;18(3):3211-3217. doi: 10.3892/ol.2019.10640. Epub 2019 Jul 22.
18 Prevalence of MYH germline mutations in Swiss APC mutation-negative polyposis patients.Int J Cancer. 2006 Apr 15;118(8):1937-40. doi: 10.1002/ijc.21470.
19 Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.Exp Mol Pathol. 2008 Dec;85(3):201-6. doi: 10.1016/j.yexmp.2008.09.006. Epub 2008 Oct 11.
20 Genome-wide association study identifies seven novel susceptibility loci for primary open-angle glaucoma.Hum Mol Genet. 2018 Apr 15;27(8):1486-1496. doi: 10.1093/hmg/ddy053.
21 Cross-talk among AFAP1-AS1, ACVR1 and microRNA-384 regulates the stemness of pancreatic cancer cells and tumorigenicity in nude mice.J Exp Clin Cancer Res. 2019 Feb 28;38(1):107. doi: 10.1186/s13046-019-1051-0.
22 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
23 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
24 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
25 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
26 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
27 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
28 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
29 Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 2005 Jul 1;106(1):304-10.
30 Folate deficiency in normal human fibroblasts leads to altered expression of genes primarily linked to cell signaling, the cytoskeleton and extracellular matrix. J Nutr Biochem. 2007 Aug;18(8):541-52. doi: 10.1016/j.jnutbio.2006.11.002. Epub 2007 Feb 22.
31 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
32 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
33 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.